News Round-Up
27 April 2024
by Toby Young
The Green Agenda Will Lead to Civil War
26 April 2024
by Ben Pile
New data from PHE suggests the vaccines are 90% effective in preventing symptomatic infection in the over 65s. But the study has numerous problems. It also shows the post-vaccine infection spike again.
The vaccine rollout is set to extend to those below the age of 40 from Thursday, with the Pfizer and Moderna vaccines being offered as alternatives to that made by AstraZeneca "where possible".
Two new vaccines studies from PHE bring encouraging news on protection against hospitalisation and death. But they leave me with more questions than answers.
A new population study from Israel published in the Lancet finds that the Pfizer vaccine is 95% effective once a person is fully vaccinated. But have they taken into account that infections were falling anyway?
Canada has become the first country to authorise the use of the Pfizer Covid vaccine for children aged 12-15. U.S. regulators are expected to do the same in the coming days.
The Israeli Health Ministry has raised concerns that there could be a link between the Pfizer Covid vaccine and heart issues, particularly among younger men.
The E.U. will soon seal its departure from the AstraZeneca Covid vaccine by signing off on the world's biggest vaccine deal yet, buying up to 1.8 billion doses of the Pfizer vaccine to last up until 2023.
A new study – the largest of its kind – has found that the Pfizer vaccine produces an "off the scale" immune response likely to protect against the Brazilian, Kent and Wuhan variants.
A new study from UCL claims to find that a single vaccine dose provides 62% protection for care home residents. A closer look, however, tells a more complex story.
© Skeptics Ltd.